The U.S. e-cigarette and vape market was valued at $15-billion last year and a “growing emphasis on adopting safer alternatives to smoking” is expected to drive 28 per cent annual growth through 2028, according to Grand View Research.
CBD, a non-psychoactive compound derived mainly from the hemp variant of cannabis, saw a massive rise in popularity last year as more people turned to it for relaxation during the months-long isolation caused by COVID-19, lifting sales of pot producers.
Canopy has looked to capitalize on the increased demand and launched various products such as CBD-infused beverage line in Canada and the United States and even a new line of cannabis-infused soft chews and drops for dogs.
Canopy said its Whisl pods will be available in three variants, each targeting mood management during different parts of a day. Each pod will contain 200 milligram of a purified form of CBD, sourced from licensed hemp providers within the United States.
Canopy said its nicotine-free vaporizer will be available in more than 3,000 Circle K convenience stores in 21 states from Oct. 1.
Your time is valuable. Have the Top Business Headlines newsletter conveniently delivered to your inbox in the morning or evening. Sign up today.